# Methoxy Polyethylene Glycol- Epoetin β

## Mircera inj 50mcg/0.3mL

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | IMIR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Indications        | Treatment of symptomatic anemia associated with chronic kidney disease (CKD). Not indicated for the treatment of anemia due to cancer chemotherapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Dosing             | Adult without treated with an ESA before， initially IV/SC 0.6 mcg/kg as a single dose every 2 weeks. Once Hb has been maintained between 10-12 g/dL， one time per month could be considerated， with double dose of initial dose. Adult currently treated with an ESA， IV/SC every 2 weeks or once monthly. Previous dose of Epoetin α or β < 4000 u/week or Darbepoetin α < 20 mcg/week: 80 mcg/month or 40 mcg every 2 weeks. Previous dose of Epoetin α or β 4000-< 8000 u/week or Darbepoetin α 20-< 40 mcg/week: 120 mcg/month or 60 mcg every 2 weeks. Previous dose of Epoetin α or β 8000-16000 u/week or Darbepoetin α 40-80 mcg/week: 200 mcg/month or 100 mcg every 2 weeks. Previous dose of Epoetin α or β > 16000 u/week or Darbepoetin α > 80 mcg/week: 360 mcg/month or 180 mcg every 2 weeks. Dose adjustments should not be made more than once per month. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Uncontrolled hypertension.Neonates: injections containing benzyl alcohol.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Adverse Effects    | Hypertension， diarrhea， nasopharyngitis， headache & upper respiratory tract infections. Increased mortality， serious cardiovascular & thromboembolic events; Increased mortality and/or tumor progression; seizures; pure red cell aplasia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Pregnancy          | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

